170 related articles for article (PubMed ID: 3071777)
1. [Changes in the immunologic profile of newly-diagnosed diabetic patients during the first year of the disease].
Pizzul MG; Betterle C; De Campo C; Tonini G; Marinoni S; Pocecco M
Pediatr Med Chir; 1988; 10(5):481-5. PubMed ID: 3071777
[TBL] [Abstract][Full Text] [Related]
2. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies, immunoglobulins, complement and circulating immune complexes in acute malaria.
Jhaveri KN; Ghosh K; Mohanty D; Parmar BD; Surati RR; Camoens HM; Joshi SH; Iyer YS; Desai A; Badakere SS
Natl Med J India; 1997; 10(1):5-7. PubMed ID: 9069696
[TBL] [Abstract][Full Text] [Related]
4. [Cytoplasmic islet-cell antibodies (ICA) and cytoplasmic complement- fixing antibodies (CF-ICA) in patients with newly detected and short-lasting diabetes mellitus type 1].
Majkowska L; Czekalski S; Skwira J
Pol Tyg Lek; 1990 May 7-14; 45(19-20):384-8. PubMed ID: 2255656
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes, insulin antibodies, and deposits of immunoglobulins in the skin in diabetes.
Josephsen PG; Permin H; Juhl F; Enk B; Svehag SE
Dan Med Bull; 1986 Jun; 33(3):171-4. PubMed ID: 3720367
[TBL] [Abstract][Full Text] [Related]
6. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
[TBL] [Abstract][Full Text] [Related]
7. Islet cell antibodies, circulating immune complexes and antinuclear antibodies in diabetes mellitus.
Helmke K; Otten A; Mäser E; Wolf H; Federlin K
Horm Metab Res; 1987 Jul; 19(7):312-5. PubMed ID: 3305275
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic islet cell antibodies in type I diabetics in Israel and their first-degree relatives.
Assa S; Karp M; Erster B; Laron Z
Isr J Med Sci; 1985 Sep; 21(9):727-30. PubMed ID: 3902719
[TBL] [Abstract][Full Text] [Related]
9. Characterization of islet cell antibody in insulin dependent diabetes: evidence for IgG1 subclass restriction and polyclonality.
Millward A; Hussain MJ; Peakman M; Pyke DA; Leslie RD; Vergani D
Clin Exp Immunol; 1988 Feb; 71(2):353-6. PubMed ID: 3127094
[TBL] [Abstract][Full Text] [Related]
10. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
12. [Immunologic parameters in insulin-dependent diabetes mellitus in children].
Strnová J; Páleníková O; Horváthová J; Getlík A
Cesk Pediatr; 1990 Jan; 45(1):16-7. PubMed ID: 2203546
[TBL] [Abstract][Full Text] [Related]
13. [Variations in indicators of humoral immunity in type I diabetes].
Hulinský I; Dryáková M; Kaslík J; Malý J
Vnitr Lek; 1990 Feb; 36(2):147-53. PubMed ID: 2186571
[TBL] [Abstract][Full Text] [Related]
14. Is immunity in diabetic patients influencing the susceptibility to infections? Immunoglobulins, complement and phagocytic function in children and adolescents with type 1 diabetes mellitus.
Liberatore RR; Barbosa SF; Alkimin Md; Bellinati-Pires R; Florido MP; Isaac L; Kirschfink M; Grumach AS
Pediatr Diabetes; 2005 Dec; 6(4):206-12. PubMed ID: 16390389
[TBL] [Abstract][Full Text] [Related]
15. Complement activation in diabetes mellitus.
Bergamaschini L; Gardinali M; Poli M; Lorini R; Bosi E; Agostoni A
J Clin Lab Immunol; 1991 Jul; 35(3):121-7. PubMed ID: 1688167
[TBL] [Abstract][Full Text] [Related]
16. Multiple antibody status in type 1 diabetic patients and subjects at various risk with islet-cell antibodies.
Maugendre D; Chaillous L; Rohmer V; Lecomte P; Marechaud R; Saï P; Marre M; Charbonnel B; Allannic H; Delamaire M
Diabetes Metab; 1997 Sep; 23(4):320-6. PubMed ID: 9342546
[TBL] [Abstract][Full Text] [Related]
17. Humoral immune abnormalities in human brucellosis.
Gotuzzo E; Bocanegra TS; Alarcón GS; Carrillo C; Espinoza LR
Allergol Immunopathol (Madr); 1985; 13(5):417-24. PubMed ID: 4083235
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the immune system in Down's syndrome patients].
Rascón Trincado MV; Lorente Toledano F; Muriel Ramos MM; Romo Cortina A; Salazar Villalobos V
Allergol Immunopathol (Madr); 1984; 12(1):45-52. PubMed ID: 6233858
[TBL] [Abstract][Full Text] [Related]
19. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population.
Krochik AG; Mazza CS; Valdez SN; Stumpo RR; Papouchado ML; Iacono RF; Cardoso Landaburu AC; Sica MP; Ozuna B; Poskus E
Medicina (B Aires); 2001; 61(3):279-83. PubMed ID: 11474874
[TBL] [Abstract][Full Text] [Related]
20. Negative correlation between ICA persistence and beta cell restoration after IDDM diagnosis.
Manna R; Salvatore M; Scuderi F; Papa G; Marietti G; Greco AV; Ghirlanda G; Gambassi G
Diabetes Res; 1988 Nov; 9(3):101-3. PubMed ID: 3072142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
